Table 2. Characteristics of patients.
| Control mean ±SD (n = 12) | BMMNC mean ±SD (n = 14) | |
|---|---|---|
| Age | 59 ±13 | 60 ±10 |
| Male gender | 10 | 13 |
| Previous Infarct (n) | 0 | 1 |
| Diabetes mellitus (n) | 0 | 4 |
| Time delay to thrombolysis (h) | 3.7 ±4.4 | 2.8 ±2.7 |
| delay Time from symptoms to PCI (h) | 59 ±10 | 52 ±12 |
| Troponin 2 days after AMI (μg/L) | 3.0 ±2.0 | 1.9 ±0.6 |
| Severity of CAD | ||
| One-vessel | 8 | 6 |
| Two-vessel | 3 | 5 |
| Three-vessel | 1 | 3 |
| Number of injected BMCs | ||
| Number of mononuclear cells (x106) | 461 ±130 | |
| Number of CD34+ cells (x106) | 2.8 ±1.7 | |
| Medication at discharge (n) | ||
| Aspirin | 12 | 13 |
| Betablocker | 9 | 9 |
| Clopidogrel | 1 | 3 |
| Statin | 12 | 14 |
| Diuretic | 3 | 4 |
| ACE-inhibitor/ATII recaptor blocker | 8 | 12 |
| Medication at 6 month follow-up (n) | ||
| Aspirin | 12 | 14 |
| Betablocker | 12 | 12 |
| Clopidogrel | 12 | 12 |
| Statin | 12 | 14 |
| Diuretic | 1 | 3 |
| ACE-inhibitor/ATII recaptor blocker | 8 | 10 |
| Major complications (n) | 0 | 0 |
| Before discharge from hospital |